FDA.reportPublic FDA data

BENDEKA 25 MG/ML Injectable Solution

RxCUI
1726102
RxNorm name
BENDEKA 25 MG/ML Injectable Solution
Display name
BENDEKA 25 MG/ML Injectable Solution
Full name
BENDEKA 25 MG/ML Injectable Solution
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:15

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BendekaBENDAMUSTINE HYDROCHLORIDETeva Pharmaceuticals USA, Inc.ace9a43b-f9bd-4896-abfe-0ef4fec67ddf2024-01-19Warnings, Adverse reactionsExact identifier
rxcui: 1726102

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
ace9a43b-f9bd-4896-abfe-0ef4fec67ddfBENDEKA 25 MG/ML Injectable SolutionPSN22These highlights do not include all the information needed to use BENDEKA safely and effectively. See full prescribing information for BENDEKA. BENDEKA ® (bendamustine hydrochloride injection), for intravenous use Initial U.S. Approval: 200820240119
ace9a43b-f9bd-4896-abfe-0ef4fec67ddfBendeka 25 MG/ML Injectable SolutionSY22These highlights do not include all the information needed to use BENDEKA safely and effectively. See full prescribing information for BENDEKA. BENDEKA ® (bendamustine hydrochloride injection), for intravenous use Initial U.S. Approval: 200820240119
ace9a43b-f9bd-4896-abfe-0ef4fec67ddfbendamustine hydrochloride 25 MG/ML Injectable Solution [Bendeka]SBD22These highlights do not include all the information needed to use BENDEKA safely and effectively. See full prescribing information for BENDEKA. BENDEKA ® (bendamustine hydrochloride injection), for intravenous use Initial U.S. Approval: 200820240119